Pharmaceutical giants like Johnson & Johnson as well as smaller startups are investing in psychedelic drug development, and both are pursuing FDA approval for their patented psilocybin formulations.

A steep decline in teens who misused prescription medications in the past year, from 11% to 2%, surprises researchers.

A new nanoparticle treatment approach aims to reduce side effects and treatment burden for people with sickle cell disease.

Central America’s forests are critically important habitat for many forest birds, including endangered species. Narco-traffickers are cutting down trees, leaving birds with nowhere to go.

Mushrooms that contain psilocybin generate psychedelic experiences by disrupting a critical network of brain areas involved in introspective thinking.

Why are some individuals at greater risk for developing opioid dependence and addiction? Two neuroscientists at Rowan University discuss their latest findings.

The process of converting food into nutritional information is more than just a scientific process. It involves many political and technical compromises that continue to shape the food industry today.

By helping microbes withstand industrial processing, the method could make it easier to harness the benefits of microorganisms used as medicines and in agriculture.

In many cases of malignant melanoma, the effect of targeted treatment is lost over time. New research clarifies how.

A new gene-silencing tool shows promise as a future therapy against prion diseases and paves the way for new approaches to treating disease.